Regorafenib inhibits ERK signaling and suppresses the growth of sorafenib-resistant cells in human hepatocellular carcinoma

被引：0
|
作者：
Hashiba, Tomomi [1 ]
Yamashita, Taro [1 ]
Okada, Hikari [1 ]
Nio, Kouki [1 ]
Hayashi, Takehiro [1 ]
Nomura, Yoshimoto [1 ]
Yoshida, Mariko [1 ]
Hayashi, Tomoyuki [1 ]
Oishi, Naoki [1 ]
Honda, Masao [1 ]
Kaneko, Shuichi [1 ]
机构：
[1] Kanazawa Univ, Grad Sch Med, Gastroenterol, Kanazawa, Ishikawa, Japan
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1953
引用
收藏
页码：1160A / 1160A
页数：1
相关论文
共 50 条
  • [31] Response of Scalp and Skull Metastasis to Anti-PD-1 Antibody Combined with Regorafenib Treatment in a Sorafenib-Resistant Hepatocellular Carcinoma Patient and a Literature Review
    Long, Xin
    Zhang, Lei
    Wang, Wen-qiang
    Zhang, Er-lei
    Lv, Xing
    Huang, Zhi-yong
    ONCOTARGETS AND THERAPY, 2022, 15 : 703 - 716
  • [32] Metabolic implication of tigecycline as an efficacious second-line treatment for sorafenib-resistant hepatocellular carcinoma
    Messner, Martina
    Schmitt, Sabine
    Ardelt, Maximilian A.
    Froehlich, Thomas
    Mueller, Martin
    Pein, Helmut
    Huber-Cantonati, Petra
    Ortler, Carina
    Koenig, Lars M.
    Zobel, Lena
    Koeberle, Andreas
    Arnold, Georg J.
    Rothenfusser, Simon
    Kiemer, Alexandra K.
    Gerbes, Alexander L.
    Zischka, Hans
    Vollmar, Angelika M.
    Pachmayr, Johanna
    FASEB JOURNAL, 2020, 34 (09): : 11860 - 11882
  • [33] Glycine inhibits angiogenic signaling in human hepatocellular carcinoma cells
    Bruns, Helge
    Petrulionis, Marius
    Schultze, Daniel
    Al Saeedi, Mohammed
    Lin, Shibo
    Yamanaka, Kenya
    Ambrazevicius, Marius
    Strupas, Kestutis
    Schemmer, Peter
    AMINO ACIDS, 2014, 46 (04) : 969 - 976
  • [34] Glycine inhibits angiogenic signaling in human hepatocellular carcinoma cells
    Helge Bruns
    Marius Petrulionis
    Daniel Schultze
    Mohammed Al Saeedi
    Shibo Lin
    Kenya Yamanaka
    Marius Ambrazevičius
    Kęstutis Strupas
    Peter Schemmer
    Amino Acids, 2014, 46 : 969 - 976
  • [35] Stemness Analysis Uncovers That The Peroxisome Proliferator-Activated Receptor Signaling Pathway Can Mediate Fatty Acid Homeostasis In Sorafenib-Resistant Hepatocellular Carcinoma Cells
    Feng, Tingze
    Wu, Tianzhi
    Zhang, Yanxia
    Zhou, Lang
    Liu, Shanshan
    Li, Lin
    Li, Ming
    Hu, Erqiang
    Wang, Qianwen
    Fu, Xiaocong
    Zhan, Li
    Xie, Zijing
    Xie, Wenqin
    Huang, Xianying
    Shang, Xuan
    Yu, Guangchuang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [36] Teroxirone suppresses growth and motility of human hepatocellular carcinoma cells
    Kim, Seung-Hun
    Wang, Wen-Hsing
    Wang, Jing-Ping
    Hsieh, Chang-Heng
    Fang, Kang
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 99 : 997 - 1008
  • [37] Upregulation of PD-L1 expression promotes epithelial-to-mesenchymal transition in sorafenib-resistant hepatocellular carcinoma cells
    Xu, Gui-Li
    Ni, Cai-Fang
    Liang, Han-Si
    Xu, Yun-Hua
    Wang, Wan-Sheng
    Shen, Jian
    Li, Ming-Ming
    Zhu, Xiao-Li
    GASTROENTEROLOGY REPORT, 2020, 8 (05): : 390 - 398
  • [38] ESTABLISHMENT OF SORAFENIB-RESISTANT MOUSE RENAL CELL CARCINOMA RENCA CELLS AND CHARACTERIZATION OF THEIR ACQUIRED RESISTANT MECHANISM
    Kusuda, Yuji
    Miyake, Hideaki
    Sakai, Iori
    Fujisawa, Masato
    JOURNAL OF UROLOGY, 2012, 187 (04): : E121 - E121
  • [39] Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma
    You-Liang Lai
    Kai-Hung Wang
    Hsing-Pang Hsieh
    Wan-Ching Yen
    Journal of Biomedical Science, 29
  • [40] Sorafenib suppresses desmoid tumor growth and invasion via inhibition of ERK signaling
    Rosenberg, Laura M.
    Bertagnolli, Monica M.
    Cho, Nancy L.
    CANCER RESEARCH, 2014, 74 (19)
12345